• LAST PRICE
    18.0500
  • TODAY'S CHANGE (%)
    Trending Up0.1000 (0.5571%)
  • Bid / Lots
    17.9900/ 6
  • Ask / Lots
    18.1400/ 6
  • Open / Previous Close
    18.1300 / 17.9500
  • Day Range
    Low 17.8000
    High 18.3000
  • 52 Week Range
    Low 4.0517
    High 61.9000
  • Volume
    55,582
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Monday's close: 17.95
TimeVolumeCRBP
09:32 ET186118.085
09:35 ET47518.2
09:37 ET589418.12
09:39 ET32518.142
09:44 ET10018.05
09:46 ET10018.06
09:48 ET371018.23
09:50 ET50018.06
09:51 ET10018.105
10:00 ET10018.135
10:04 ET60018.201
10:06 ET119618.14
10:08 ET81018.1433
10:09 ET10018.09
10:11 ET117617.99
10:20 ET40017.86
10:24 ET137417.95
10:29 ET20017.95
10:33 ET22017.916
10:40 ET30018.01
10:45 ET361918.07
10:47 ET10018.06
10:51 ET10018.0265
10:54 ET40018.11
10:56 ET110018.17
11:02 ET10018.22
11:03 ET110018.17
11:05 ET101518.15
11:12 ET66018
11:18 ET48717.9
11:20 ET39017.865
11:21 ET70017.8454
11:27 ET75017.95
11:34 ET125017.91
11:41 ET40017.89
11:48 ET20017.95
11:50 ET109717.825
11:52 ET31917.88
11:59 ET116417.97
12:03 ET70017.955
12:10 ET10017.96
12:12 ET10018.02
12:15 ET55417.9
12:19 ET10018.03
12:21 ET20018.05
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesCRBP
Corbus Pharmaceuticals Holdings Inc
212.8M
-3.8x
---
United StatesLXEO
Lexeo Therapeutics Inc
213.9M
-2.6x
---
United StatesSLDB
Solid Biosciences Inc
216.2M
-2.0x
---
United StatesXBIT
XBiotech Inc
208.1M
-6.3x
---
United StatesOKUR
Onkure Therapeutics Inc
207.4M
-1.2x
---
United StatesCLYM
Climb Bio Inc
205.0M
-1.4x
---
As of 2024-11-26

Company Information

Corbus Pharmaceuticals Holdings, Inc. is a precision oncology company with a diversified portfolio. The Company's pipeline is comprised of two experimental drugs targeting solid tumors: CRB-701, which is an antibody drug conjugate (ADC) that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload and CRB-601, which is an anti-integrin monoclonal antibody that blocks the activation of TGFβ expressed on cancer cells. Its pipeline also includes CRB-913, which is a highly peripherally restricted cannabinoid type-1 (CB1) receptor inverse agonist for the treatment of obesity. It has in-licensed the intellectual property for CRB-601 from Dr. Stephen Nishimura's laboratory at the University of California, San Francisco. The Company does not own or operate manufacturing facilities and relies on third-party contract manufacturing organizations or licensing partners to supply it with drugs for pre-clinical and clinical studies and commercial activities.

Contact Information

Headquarters
500 River Ridge DriveNORWOOD, MA, United States 02062
Phone
617-963-0103
Fax
---

Executives

Independent Director
Alan Holmer
Chief Executive Officer, Director
Yuval Cohen
Chief Financial Officer
Sean Moran
Chief Medical Officer
Dominic Smethurst
Independent Director
Anne Altmeyer

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$212.8M
Revenue (TTM)
$0.00
Shares Outstanding
12.2M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
2.59
EPS
$-4.69
Book Value
$-1.56
P/E Ratio
-3.8x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.